Skip to main content

Hydrochlorothiazide News

Related terms: HCTZ

Risk for Dementia Reduced in Association With Antihypertensive Use

WEDNESDAY, Sept. 13, 2023 – Antihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 in JAMA Network...

FDA Medwatch Alert: Accord Healthcare Inc. Issues Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 mg Due to Labeling Mix-up

Accord Healthcare Inc. is voluntarily recalling One lot (Lot PW05264 – 46632 Bottles, NDC 16729-182-01) of Hydrochlorothiazide Tablets USP, 12.5 mg, to the consumer level.A 100 count bottle of H...

FDA Medwatch Alert: Hydrochlorothiazide Tablets by Unichem Pharmaceuticals (USA), Inc: Recall - Potential Presence of Foreign Tablets Contamination

ISSUE: Unichem Pharmaceuticals (USA), Inc. (Unichem) is voluntarily recalling one lot of Hydrochlorothiazide Tablets 25 mg 1000-count bottle to the consumer level. This recall has been initiated as a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Edema, High Blood Pressure, Hypertension

Hydrochlorothiazide patient information at Drugs.com